Immunovant, Inc. (IMVT) Insider Trading Disclosures
Immunovant, Inc. (IMVT) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IMVT
CIK: 1764013
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 03/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 3/31/2020 12:00:00 AM
Lead Engagement PartnerJamie Molchan
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-09 | 2026-10-07 | FORM 4 | 0001702969-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-10-09 | 2026-10-07 | FORM 4 | 0001779707-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-10-09 | 2026-10-07 | FORM 4 | 0001764013-26-000112 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | FORM 4 | 0001764013-26-000110 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | FORM 4 | 0001764013-26-000108 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-09-02 | 8-K | 0001764013-26-000106 | View SEC Doc Filr Page |
| 4 | 2026-08-28 | 2026-08-28 | FORM 4 | 0001764013-26-000103 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-20 | FORM 4 | 0001973838-26-000007 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003481 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001764013-26-000101 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001764013-26-000100 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-24 | FORM 4 | 0001643071-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-23 | FORM 4 | 0001618670-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-23 | FORM 4 | 0001702969-26-000010 | View SEC Doc Filr Page |
| ARS | 2026-07-22 | 2026-03-31 | ARS | 0001764013-26-000094 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-22 | — | DEFA14A | 0001764013-26-000093 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-22 | 2026-09-02 | DEF 14A | 0001764013-26-000092 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | FORM 4 | 0001764013-26-000083 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | FORM 4 | 0001764013-26-000082 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | FORM 4 | 0001764013-26-000081 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | FORM 4 | 0001764013-26-000077 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-26 | FORM 4 | 0001764013-26-000075 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-26 | FORM 4 | 0001764013-26-000074 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-26 | FORM 4 | 0001764013-26-000073 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-26 | FORM 4 | 0001764013-26-000072 | View SEC Doc Filr Page |